# NKX2-1

## Overview
NKX2-1, also known as NK2 homeobox 1, is a gene that encodes a homeodomain transcription factor critical for the development and function of the thyroid, lungs, and brain. The protein product, thyroid transcription factor 1 (TTF-1), is involved in regulating the expression of genes essential for organogenesis and cellular differentiation. As a transcription factor, NKX2-1 plays a pivotal role in the development of the thyroid gland, the production of surfactant proteins in the lungs, and the specification of neuronal cell types in the brain (Li2013NKX21; Kimura1996The; Goulburn2011A). Mutations in the NKX2-1 gene are linked to a spectrum of disorders known as NKX2-1-related disorders, which can affect the central nervous system, pulmonary function, and thyroid activity (Guillot2010NKX21mutations; Skwara2024Differential). The gene's expression and function are intricately regulated by various signaling pathways and protein interactions, underscoring its importance in developmental biology and disease (Zhou2008Foxp2; Minoo2007Physical).

## Structure
The NKX2-1 protein, also known as thyroid transcription factor 1 (TTF-1), is a homeodomain transcription factor involved in the development of the lung, thyroid, and brain. It is encoded by the NKX2-1 gene, which produces two isoforms: a major form with 371 amino acids and a minor form with 401 amino acids. The longer isoform includes a 30 amino acid N-terminal extension, which is highly conserved among mammals and influences the protein's function by potentially inducing conformational changes that affect DNA binding or activation function (Li2000Two).

The homeodomain, encoded by exon III, is identical in both isoforms and is responsible for DNA binding specificity. This domain typically forms a helix-turn-helix structure, characteristic of many transcription factors (Li2000Two). The NK2-specific domain (NK2-SD) within NKX2-1 may function as an accessory DNA-binding domain or a protein-protein interaction interface, although it does not significantly contribute to DNA-binding specificity (Watada2000Intramolecular).

Post-translational modifications, particularly phosphorylation, play a crucial role in the protein's function, influencing its transcriptional activity and organ development roles (Silberschmidt2011In). The presence of alternative translational initiation sites results in different polypeptides, indicating a complex regulation of its expression and function (Li2000Two).

## Function
The NKX2-1 gene, also known as NK2 homeobox 1, encodes a transcription factor that plays a critical role in the development and function of the thyroid, lungs, and brain. In the thyroid, NKX2-1 regulates the expression of genes essential for thyroid hormone biosynthesis, such as thyroglobulin and thyroid peroxidase, by binding to enhancer elements upstream of these genes (Boggaram2008Thyroid; Kimura1996The). In the lungs, NKX2-1 is crucial for the expression of surfactant proteins, including SP-A, SP-B, and SP-C, which are vital for reducing surface tension in the alveoli and preventing lung collapse (Li2013NKX21; Delestrain2023Deciphering). It is predominantly expressed in alveolar type II epithelial cells, where it regulates lung-specific gene expression (Boggaram2008Thyroid).

In the brain, NKX2-1 is involved in the specification of GABAergic interneurons and oligodendrocytes, contributing to proper neural function (Delestrain2023Deciphering). It is expressed in the ventral forebrain during development, where it influences the differentiation of neuronal cell types, including GABAergic and dopaminergic neurons (Goulburn2011A). The gene's activity is regulated by signaling pathways such as those involving retinoic acid and sonic hedgehog, which are essential for maintaining NKX2-1 expression in progenitor cells (Goulburn2011A).

## Clinical Significance
Mutations in the NKX2-1 gene, also known as NK2 homeobox 1, are associated with a range of disorders collectively referred to as NKX2-1-related disorders or brain-lung-thyroid syndrome. These disorders can manifest with symptoms affecting the central nervous system, lungs, and thyroid gland. Neurological symptoms often include chorea, choreoathetosis, developmental delay, cognitive deficits, hypotonia, myoclonus, ataxia, and psychiatric disorders. Chorea is a particularly common symptom and can be misdiagnosed as Huntington's disease (Skwara2024Differential; Parnes2018Is).

Pulmonary dysfunctions such as respiratory distress syndrome and interstitial lung disease are also prevalent, often due to the gene's role in regulating surfactant proteins essential for lung function (Guillot2010NKX21mutations). Thyroid dysfunction, including congenital hypothyroidism, is another common feature (Doyle2004Autosomal; Krude2002Choreoathetosis).

The gene's mutations can be both sporadic and familial, with a variety of pathogenic mutations identified. These mutations can lead to either gain or loss of function, affecting the gene's normal interactions and resulting in the diverse clinical manifestations observed in affected individuals (Carre2009Five; Thorwarth2014Comprehensive).

## Interactions
NKX2-1, also known as thyroid transcription factor 1 (TTF-1), is involved in various physical interactions with other proteins, particularly in lung epithelial cells. It interacts with the winged helix/forkhead family of FOXA transcription factors, specifically FOXA1 and FOXA2. The interaction between NKX2-1 and FOXA1 is inhibitory and occurs through the NKX2-1 homeodomain in a DNA-independent manner. On the SpC gene, which lacks a FOXA1 binding site, FOXA1 attenuates NKX2-1-dependent transcription. Conversely, on the Ccsp gene, which includes both NKX2-1 and FOXA1 binding sites, the two factors additively activate transcription (Minoo2007Physical).

NKX2-1 also interacts with Foxp2, which inhibits NKX2-1-mediated transcription of the surfactant protein C (SP-C) gene. This interaction is dose-dependent and does not require Foxp2 to bind directly to the SP-C promoter. The interaction likely disrupts NKX2-1's ability to bind DNA or interact with co-activators, thereby inhibiting its function (Zhou2008Foxp2). These interactions highlight NKX2-1's role in regulating gene expression through complex protein-protein interactions.


## References


[1. (Li2013NKX21) Yong Li, Kristel Eggermont, Veerle Vanslembrouck, and Catherine M. Verfaillie. Nkx2-1 activation by smad2 signaling after definitive endoderm differentiation in human embryonic stem cell. Stem Cells and Development, 22(9):1433–1442, May 2013. URL: http://dx.doi.org/10.1089/scd.2012.0620, doi:10.1089/scd.2012.0620. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/scd.2012.0620)

[2. (Boggaram2008Thyroid) Vijay Boggaram. Thyroid transcription factor-1 (ttf-1/nkx2.1/titf1) gene regulation in the lung. Clinical Science, 116(1):27–35, November 2008. URL: http://dx.doi.org/10.1042/cs20080068, doi:10.1042/cs20080068. This article has 144 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/cs20080068)

[3. (Silberschmidt2011In) Daniel Silberschmidt, Alina Rodriguez-Mallon, Prathiba Mithboakar, Gaetano Calì, Elena Amendola, Remo Sanges, Mariastella Zannini, Marzia Scarfò, Pasquale De Luca, Lucio Nitsch, Roberto Di Lauro, and Mario De Felice. In vivo role of different domains and of phosphorylation in the transcription factor nkx2-1. BMC Developmental Biology, February 2011. URL: http://dx.doi.org/10.1186/1471-213x-11-9, doi:10.1186/1471-213x-11-9. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-213x-11-9)

[4. (Delestrain2023Deciphering) Céline Delestrain, Abdel Aissat, Elodie Nattes, Isabelle Gibertini, Valérie Lacroze, Stéphanie Simon, Xavier Decrouy, Alix de Becdelièvre, Pascale Fanen, and Ralph Epaud. Deciphering an isolated lung phenotype of nkx2-1 frameshift pathogenic variant. Frontiers in Pediatrics, January 2023. URL: http://dx.doi.org/10.3389/fped.2022.978598, doi:10.3389/fped.2022.978598. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fped.2022.978598)

[5. (Guillot2010NKX21mutations) Loïc Guillot, Aurore Carré, Gabor Szinnai, Mireille Castanet, Elodie Tron, Francis Jaubert, Isabelle Broutin, François Counil, Delphine Feldmann, Annick Clement, Michel Polak, and Ralph Epaud. Nkx2-1mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in “brain-lung-thyroid syndrome”. Human Mutation, 31(2):E1146–E1162, February 2010. URL: http://dx.doi.org/10.1002/humu.21183, doi:10.1002/humu.21183. This article has 101 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21183)

[6. (Doyle2004Autosomal) Daniel A. Doyle, Iris Gonzalez, Becky Thomas, and Mena Scavina. Autosomal dominant transmission of congenital hypothyroidism, neonatal respiratory distress, and ataxia caused by a mutation of nkx2-1. The Journal of Pediatrics, 145(2):190–193, August 2004. URL: http://dx.doi.org/10.1016/j.jpeds.2004.04.011, doi:10.1016/j.jpeds.2004.04.011. This article has 81 citations.](https://doi.org/10.1016/j.jpeds.2004.04.011)

[7. (Kimura1996The) S Kimura, Y Hara, T Pineau, P Fernandez-Salguero, C H Fox, J M Ward, and F J Gonzalez. The t/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes &amp; Development, 10(1):60–69, January 1996. URL: http://dx.doi.org/10.1101/gad.10.1.60, doi:10.1101/gad.10.1.60. This article has 963 citations.](https://doi.org/10.1101/gad.10.1.60)

[8. (Goulburn2011A) Adam L. Goulburn, Darym Alden, Richard P. Davis, Suzanne J. Micallef, Elizabeth S. Ng, Qing C. Yu, Sue Mei Lim, Chew-Li Soh, David A. Elliott, Tanya Hatzistavrou, Justin Bourke, Bradley Watmuff, Richard J. Lang, John M. Haynes, Colin W. Pouton, Antonietta Giudice, Alan O. Trounson, Stewart A. Anderson, Edouard G. Stanley, and Andrew G. Elefanty. A targeted nkx2.1 human embryonic stem cell reporter line enables identification of human basal forebrain derivatives. Stem Cells, 29(3):462–473, March 2011. URL: http://dx.doi.org/10.1002/stem.587, doi:10.1002/stem.587. This article has 89 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/stem.587)

[9. (Carre2009Five) A. Carre, G. Szinnai, M. Castanet, S. Sura-Trueba, E. Tron, I. Broutin-L’Hermite, P. Barat, C. Goizet, D. Lacombe, M.-L. Moutard, C. Raybaud, C. Raynaud-Ravni, S. Romana, H. Ythier, J. Leger, and M. Polak. Five new ttf1/nkx2.1 mutations in brain-lung-thyroid syndrome: rescue by pax8 synergism in one case. Human Molecular Genetics, 18(12):2266–2276, March 2009. URL: http://dx.doi.org/10.1093/hmg/ddp162, doi:10.1093/hmg/ddp162. This article has 158 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddp162)

[10. (Watada2000Intramolecular) Hirotaka Watada, Raghavendra G. Mirmira, Julie Kalamaras, and Michael S. German. Intramolecular control of transcriptional activity by the nk2-specific domain in nk-2 homeodomain proteins. Proceedings of the National Academy of Sciences, 97(17):9443–9448, August 2000. URL: http://dx.doi.org/10.1073/pnas.97.17.9443, doi:10.1073/pnas.97.17.9443. This article has 83 citations.](https://doi.org/10.1073/pnas.97.17.9443)

[11. (Skwara2024Differential) Julia Skwara, Maciej Nowicki, Lucia Sharif, Łukasz Milanowski, Jarosław Dulski, Ewelina Elert-Dobkowska, Katarzyna Skrzypek, Dorota Hoffman-Zacharska, Dariusz Koziorowski, and Jarosław Sławek. Differential diagnosis of huntington’s disease− neurological aspects of nkx2-1-related disorders. Journal of Neural Transmission, 131(9):1013–1024, June 2024. URL: http://dx.doi.org/10.1007/s00702-024-02800-3, doi:10.1007/s00702-024-02800-3. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00702-024-02800-3)

[12. (Li2000Two) Changgong Li, Jiaxin Cai, Quping Pan, and Parviz Minoo. Two functionally distinct forms of nkx2.1 protein are expressed in the pulmonary epithelium. Biochemical and Biophysical Research Communications, 270(2):462–468, April 2000. URL: http://dx.doi.org/10.1006/BBRC.2000.2443, doi:10.1006/bbrc.2000.2443. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/BBRC.2000.2443)

[13. (Zhou2008Foxp2) Beiyun Zhou, Qian Zhong, Parviz Minoo, Changgong Li, David K. Ann, Baruch Frenkel, Edward E. Morrisey, Edward D. Crandall, and Zea Borok. Foxp2 inhibits nkx2.1-mediated transcription of sp-c via interactions with the nkx2.1 homeodomain. American Journal of Respiratory Cell and Molecular Biology, 38(6):750–758, June 2008. URL: http://dx.doi.org/10.1165/rcmb.2007-0350OC, doi:10.1165/rcmb.2007-0350oc. This article has 51 citations and is from a peer-reviewed journal.](https://doi.org/10.1165/rcmb.2007-0350OC)

[14. (Minoo2007Physical) Parviz Minoo, Lingyan Hu, Yiming Xing, Nian Ling Zhu, Hongyan Chen, Min Li, Zea Borok, and Changgong Li. Physical and functional interactions between homeodomain nkx2.1 and winged helix/forkhead foxa1 in lung epithelial cells. Molecular and Cellular Biology, 27(6):2155–2165, March 2007. URL: http://dx.doi.org/10.1128/MCB.01133-06, doi:10.1128/mcb.01133-06. This article has 82 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.01133-06)

[15. (Krude2002Choreoathetosis) Heiko Krude, Barbara Schütz, Heike Biebermann, Arpad von Moers, Dirk Schnabel, Heidi Neitzel, Holger Tönnies, Dagmar Weise, Antony Lafferty, Siegfried Schwarz, Mario DeFelice, Andreas von Deimling, Frank van Landeghem, Roberto DiLauro, and Annette Grüters. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human nkx2-1 haploinsufficiency. Journal of Clinical Investigation, 109(4):475–480, February 2002. URL: http://dx.doi.org/10.1172/jci14341, doi:10.1172/jci14341. This article has 10 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci14341)

[16. (Thorwarth2014Comprehensive) Anne Thorwarth, Sarah Schnittert-Hübener, Pamela Schrumpf, Ines Müller, Sabine Jyrch, Christof Dame, Heike Biebermann, Gunnar Kleinau, Juri Katchanov, Markus Schuelke, Grit Ebert, Anne Steininger, Carsten Bönnemann, Knut Brockmann, Hans-Jürgen Christen, Patricia Crock, Francis deZegher, Matthias Griese, Jacqueline Hewitt, Sten Ivarsson, Christoph Hübner, Klaus Kapelari, Barbara Plecko, Dietz Rating, Iva Stoeva, Hans-Hilger Ropers, Annette Grüters, Reinhard Ullmann, and Heiko Krude. Comprehensive genotyping and clinical characterisation reveal 27 novel nkx2-1 mutations and expand the phenotypic spectrum. Journal of Medical Genetics, 51(6):375–387, April 2014. URL: http://dx.doi.org/10.1136/jmedgenet-2013-102248, doi:10.1136/jmedgenet-2013-102248. This article has 81 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmedgenet-2013-102248)

[17. (Parnes2018Is) Mered Parnes, Hassaan Bashir, and Joseph Jankovic. Is benign hereditary chorea really benign? brain‐lung‐thyroid syndrome caused by nkx2‐1 mutations. Movement Disorders Clinical Practice, 6(1):34–39, November 2018. URL: http://dx.doi.org/10.1002/mdc3.12690, doi:10.1002/mdc3.12690. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/mdc3.12690)